Novartis AG (ADR) news

   Watch this stock
Showing stories 1 - 5 of about 5   

Articles published

NVS 99.56 -0.80 (-0.80%)
price chart
Basic patent and SPC � what do they actually cover?
Novartis AG had requested injunctive relief against Actavis Deutschland GmbH & Co. KG, enjoining them from distributing a generic combination medicament containing the active ingredients Valsartan and Hydrochlorothiazide (HCTZ1) for the treatment of ...
Related articles »  
New pharmacovigilance system debuts in EU
New rules governing the monitoring, identification and assessment of adverse events caused by pharmaceuticals are introduced, with the aim of making the EU-wide system for overseeing drug safety and 'benefit-risk' more transparent and robust.
Related articles »  
New tools for arguing against the use of hindsight and common sense in ...
In a victory for patent applicants and owners, a recent decision by the Federal Circuit re-emphasized the importance of the Graham factors to avoid the ever-present risk of using hindsight when making an obviousness determination, and questioned the ...
GSK speaks to IPT about the �mistakes� that led to $3bn criminal charges
Novartis to take $120m charge to fix US plant, recall OTC drugs · West's operating profit tumbles as ... Related suppliers.
Related articles »  
Roche Building On Its Strengths
... in Europe. Overall profitability was okay. Core operating profit rose about 5%, with solid 7% growth in pharmaceuticals and a 6% decline in diagnostics due to bad debt expense in emerging markets and an elevated level of system placements (which ...